| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/4/264:05 PM | $0.27 | $0.32GAAP | +18.5% | +1,348%* | $114.4M | $123.0M | +7.5% | +47% | |
| Q2 '26 | 8/5/264:05 PM | $0.13 | $0.32GAAP | +146% | — | $106.5M | $123.0M | +15.5% | — | |
| Q1 '26 | 5/6/264:05 PM | $0.01 | $0.34GAAP | +3,300% | — | $97.6M | $108.4M | +11.0% | — | |
| Q4 '25 | 3/4/264:05 PM | $0.17 | $0.11GAAP | -35.3% | n/m | $86.7M | $96.1M | +10.8% | +113% | |
| Q3 '25 | 12/9/254:05 PM | $0.16 | $0.10GAAP | -37.5% | +107%* | $82.9M | $83.5M | +0.8% | +117% |
n/m = not meaningful: one EPS figure is from around the IPO, before preferred stock converted and the share count settled, so the two are on different share counts.
* Q3 '26: Year-ago EPS (0.1) was before the IPO, on far fewer shares. Restated to today's share count from SEC filings: 0.022. Q3 '25: Year-ago EPS (-1.47) was before the IPO, on far fewer shares. Restated to today's share count from SEC filings: -1.425.
GAAP = diluted EPS as filed with the SEC.